Explore the latest in lung cancer, including advances in understanding epidemiology, risk factors, treatment biomarkers, and management.
This randomized, multisite, comparative effectiveness trial investigates whether early palliative care delivered via video or in-person visits demonstrated equivalent effects on quality of life for patients with advanced non–small cell lung cancer and their caregivers.
This cluster randomized trial examines the effect of patient-reported symptom monitoring on health-related quality of life (HRQOL) in patients with lung cancer.
This nonrandomized controlled trial investigates central nervous system (CNS) activity with lazertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
This cohort study compares the use of immune checkpoint inhibitor therapy with conventional chemotherapy in patients with non–small cell lung cancer (NSCLC) and overweight or obesity.
This secondary analysis of the Cancer and Leukemia Group B 140503 randomized clinical trial examines survival and recurrence rates in patients with small peripheral pT2 non–small cell lung cancer that was treated by either lobar or sublobar resection.
This cohort study describes lung cancer incidence, diagnosis, and outcome in individuals with Li-Fraumeni syndrome.
This nonrandomized controlled trial evaluates the clinical outcomes of atezolizumab treatment before and after chemoradiation therapy for unresectable stage III non–small cell lung cancer (NSCLC).
This Medical News article is an interview about JAMA Network highlights from the American Society of Clinical Oncology’s annual meeting, hosted by Nora Disis, MD, editor in chief of JAMA Oncology and a JAMA deputy editor.
This cross-sectional study examines e-cigarette use and lung cancer screening uptake among individuals in the US.
This quality improvement study evaluates the association between implementing a prediction-augmented shared decision-making tool and lung cancer screening uptake among US veterans.
This secondary analysis of a phase 3 randomized clinical trial compares survival and safety outcomes of intensity-modulated radiotherapy to 3-dimensional conformal radiotherapy in combined modality treatment of patients with unresectable locally advanced non–small cell lung cancer.
This nonrandomized controlled trial assesses the feasibility of using a circulating tumor DNA−guided adaptive de-escalation tyrosine kinase inhibitor strategy in patients with advanced non−small cell lung cancer to achieve complete remission after local consolidative therapy.
This randomized clinical trial examines whether patient navigation improves lung cancer screening completion among people experiencing homelessness.
This cross-sectional study investigates the prevalence of up-to-date lung cancer screening across the 50 US states and the District of Columbia in 2022.
This nonrandomized controlled trial investigates the association of an electronic health record–based lung cancer screening intervention with improved screening-related care.
This randomized clinical trial assesses whether a stepped-care model of palliative care is noninferior to early integrated palliative care based on patient-reported quality of life among patients with advanced lung cancer.
Customize your JAMA Network experience by selecting one or more topics from the list below.